RSV Conference - learnengagenetwork

Respiratory Syncytial Virus “RSV” continues to significantly burden global healthcare systems, not for infant, but also for adults. RSV Conference offer a platform that gather researchers, clinicians, and healthcare professionals to network, exchange ideas, and present the latest on prevention, diagnosis and treatment, to improve health outcomes.

RSV Conference 20-21 November 2025

Register now and join us at the RSV Conference 2025

Click here to register

Makarem Ballroom, Riyadh Marriott Hotel

Organizing Committee
Dr. Mohammed Alqahtani
Dr. Mohammed AlQahtani
Medical Microbiologist /Infectious Diseases (AMS/IPAC) and Special pathogens and public Health Microbiology

RSV Viral Structure and Function: Unraveling the Machinery of Infection

Prof. Fahad Alzamil
Prof. Fahad Alzamil
Professor and Consultant Pediatric Infectious Disease

Immune Evasion Strategies of RSV: How the Virus Outsmarts Our Defenses

Dr. Fayhan Alroqi
Allergy,Immunology, Bone Marrow Transplant Consultant

Host Genetic Factors Influencing RSV Disease Severity: A Deep Dive into Susceptibility

Dr. Mohammed Alhindi
Consultant Neonatologist

RSV Burden in Saudi Arabia: Insights from Recent Surveillance and Hospitalization Data

Dr. Rajaa Al-Raddadi
Consultant Preventive Medicine Associate Professor

Regional Perspective: RSV Epidemiology Across GCC & the Middle East

Dr. Hana Al-Abdulkarim
Director/Drug Policy and Economic Center, Ministry of National Guard Health Affairs (MNG-HA)

Economic Impact of RSV: Cost-Effectiveness of Prevention Strategies in Low- and Middle-Income Settings

Dr. Saleh Alshehri
Consultant Pediatric Emergency Physician

Bronchiolitis in Infants: Current Guidelines and Best Practices in Management

Dr. Saleh Alharbi
Consultant, Pediatrics & Pediatric Pulmonologist

Long-Term Respiratory Outcomes of Severe RSV Infection in Early Childhood

Dr. Ali Almudeer
Neonatology Consultant

RSV in High-Risk Pediatric Populations: Preterm Infants and Children with Chronic Conditions

Dr. Samer Ahmeed

Protecting the First Breath: Maternal RSV immunization

Prof. Ali Asseri
Pulmonologist

New RSV Strategy Toward All Infant Protection

Prof. Bosco Paes
Bosco Paes is Professor Emeritus in the Division of Neonatology, at McMaster University, Canada. He served as the Neonatal Intensive Care Unit Director of St Joseph’s Healthcare and McMaster Children’s Hospital in Hamilton, Ontario. He has held conjoint positions in the Department of Family Medicine and Master of Clinical Health Sciences Program. He was the Medical Director and a pioneer of the Acute Care Nurse Practitioner Program in Neonatology in Canada. Dr. Paes has received several teaching awards and has been recognized for his academic contributions by the President at McMaster University and received the inaugural Pediatric Chairs of Canada academic award. He played a research role as a member of the Pediatric Investigators Collaborative Network on Infections in Canada and the Canadian Neonatal Network. His current research focuses on respiratory syncytial virus infection and thrombosis in children.

Targeting Vulnerable Populations: Importance of RSV Prophylaxis in High-Risk Groups

Dr. Ali Albarrak

Preparing for Future Respiratory Viral Pandemics: Lessons Learned from RSV and Beyond

Dr. Fayssal Farahat
Consultant, Community and Public Health, Infection Prevention and Control Program, Ministry of National Guard Health Affairs,

RSV: Data-Driven Public Health & Future Priorities in Saudi Arabia

Prof. Bosco Paes
Bosco Paes is Professor Emeritus in the Division of Neonatology, at McMaster University, Canada. He served as the Neonatal Intensive Care Unit Director of St Joseph’s Healthcare and McMaster Children’s Hospital in Hamilton, Ontario. He has held conjoint positions in the Department of Family Medicine and Master of Clinical Health Sciences Program. He was the Medical Director and a pioneer of the Acute Care Nurse Practitioner Program in Neonatology in Canada. Dr. Paes has received several teaching awards and has been recognized for his academic contributions by the President at McMaster University and received the inaugural Pediatric Chairs of Canada academic award. He played a research role as a member of the Pediatric Investigators Collaborative Network on Infections in Canada and the Canadian Neonatal Network. His current research focuses on respiratory syncytial virus infection and thrombosis in children.

Palivizumab vs. Nirsevimab: Real-World Outcomes in Reducing Infant RSV Hospitalizations

Dr. Noura Alazhary
Pediatric infectious disease consultant

RSV in the Era of AI: Smarter Tools for Better Care

Dr. Majid Alshamrani
Consultant, Executive Director, Infection Prevention and Control Program, MNGHA-HA

RSV Vaccination for Older Adults: Real-World Impact and Sustained Protection

Dr. Mohammed Zeitouni

Unmasking the true burden of RSV in Older Adults

We are excited to announce some
of the confirmed speakers

Prof. Fahad Alzamil
Professor and Consultant Pediatric Infectious Disease

Dr. Saleh Alharbi
Pediatric Pulmonologist & Medical Director

Al Salama Hospital, Jeddah

Dr. Saleh Alshehri
Consultant, Pediatric Emergency Medicine

Prof. Ali Asseri
Pediatric Pulmonologist

Prof. Bosco Paes
Professor Emeritus in the Division of Neonatology

McMaster University, Canada

Dr. Ali Almudeer
Consultant Neonatologist

King Saud University

THANK YOU TO ALL OF OUR SPONSORS!

Pfizer-logo
Sanofi
AZ